510(k) device
Hemosil Recombiplastin 2G (8 Ml Vial)
Instrumentation Laboratory CO · Test, Time, Prothrombin (GJS, Class II) · First FDA decision Aug 15, 2007, newest Jan 22, 2014Anemia, clotting and blood disordersStroke prevention in atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Hemosil Recombiplastin 2G"
MAUDE reports
3
Brand "Hemosil Recombiplastin 2G", since 2015
PubMed studies
0
Mentioning "Hemosil Recombiplastin 2G"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Hemosil Recombiplastin 2G (8 Ml Vial)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K132722 · Decided Jan 22, 2014 · 145 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
K070005 · Decided Aug 15, 2007 · 224 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation ManagementNational determinationOn the books190.11Updated Nov 4, 2026
- Prothrombin Time (PT)National determinationOn the books190.17Updated Oct 1, 2026
- Prothrombin Time (INR) Monitor for Home Anticoagulation ManagementNational analysisReview closedCAG-00087RUpdated Sep 21, 2026
- Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Swelling of Limb)Coding analysisReview closedCAG-00201NUpdated Sep 15, 2026
- Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Pre-operative Examinations)Coding analysisReview closedCAG-00184NUpdated Sep 15, 2026
- Prothrombin Time and Fecal Occult Blood (Revision of ICD-9-CM Codes for Injury to Gastrointestinal Tract)Coding analysisReview closedCAG-00187NUpdated Sep 15, 2026
- Prothrombin Time (PT) NCD 190.17 (Addition of ICD-9-CM diagnosis code 197.7 Secondary Malignant Neoplasm of Liver)Coding analysisReview closedCAG-00404NUpdated Sep 15, 2026
- Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) tests (Removal of Unspecified Joint Replacements)Coding analysisReview closedCAG-00246NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Hemosil Recombiplastin 2G", any status and sponsor, newest update first.
No registered device study names "Hemosil Recombiplastin 2G".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Hemosil Recombiplastin 2G", and for the whole product code for context.
This brand
3 reports: 2 malfunction, 1 injury, 0 death
Whole product code GJS
12,207 reports: 11,507 malfunction, 644 injury, 34 death
Newest reports for this brand
- HEMOSIL RECOMBIPLASTIN 2G (8ML)Malfunction
INSTRUMENTATION LABORATORY CO.
1217183-2025-00030 · Received Apr 29, 2025 · Event dated Apr 6, 2025
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Incorrect, Inadequate or Imprecise Result or Readings
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
INSTRUMENTATION LABORATORY CO.
1217183-2025-00028 · Received Apr 10, 2025 · Event dated Mar 13, 2025
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Incorrect, Inadequate or Imprecise Result or Readings
Patient problem as coded: Stroke/CVA
- HEMOSIL RECOMBIPLASTIN 2G (20 ML)Malfunction
INSTRUMENTATION LABORATORY CO.
1217183-2024-00001 · Received Feb 2, 2024 · Event dated Jan 11, 2024
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Crack
Patient problem as coded: Laceration(s)
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Instrumentation Laboratory Co.
Z-1784-2013 · Started Apr 9, 2013 · Posted by FDA Jul 22, 2013
Reason given: Instrumentation Laboratory is recalling HemosIL RecombiPlasTin 2G (RPT2G), Part No. 0020009580 (8 mL Size) due to being Out of Specification.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Test, Time, Prothrombin (GJS)
Published research
The most relevant PubMed records for "Hemosil Recombiplastin 2G"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code GJS.
- microINR SystemIline Microsystems, S.L. · 510(k) 2025
- CoaguChek XS Plus SystemRoche Diagnostics · 510(k) 2025
- Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-TestingCoagusense, Inc. · 510(k) 2022
- CoaguChek XS Pro SystemRoche Diagnostics · 510(k) 2018
- Coaguchek Xs SystemRoche Diagnostics Corp. · 510(k) 2007
- Xprecia Prime Coagulation SystemUniversal Biosensors Pty, Ltd. · 510(k) 2024
- i-STAT PTplus Cartridge with the i-STAT 1 SystemAbbott Laboratories · 510(k) 2023
- STA- NeoPTimalDiagnostica Stago S.A.S · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.